Skip to main content
Insights
/ Partnering 2030 / 2024

Partnering 2030: FME Industries Report

Food, material, and electromechanical industries

In this 2024 report, we provide a unique view from the mindset of technology transfer and commercialization offices in research institutes worldwide, mapping their experiences of trying to partner with top food, material, and electromechanical (FME) companies, and their perspective on what can be done to form more healthy, productive partnerships around the best science.

Share:

Download the report

Business email
First name
Last name
Company name
Job title
Which sector best reflects your role?
By submitting this form, you agree to receive email communications from Inpart as well as the storing and processing of your personal data by Inpart as detailed in the Privacy Statement. You may unsubscribe from these communications at any time.

Key challenges for out-licensing institutes partnering with FME companies

Search eyes
Finding the right contact person
This point surfaced as the most common pain point when it comes to finding industry partners to commercialize their research, as well as better access to clear partner company scope and research requirements.
hands aligned
Misalignment between academy and industry
Several respondents pointed out a significant disconnect between the focus, goals, and timelines of academic research versus those of industry.
Communication people
Lack of feedback and communication
There is a recurring issue where industrypartners are either non-responsive or provide limited feedback on why they are not interested in a technology.

What kind of industry partners are institutes looking for?

Research Institutes demonstrated strong preferences for small and medium enterprises (SMEs) and multinational company partners , while remaining open to partnering with startups and Venture capital groups, too.

Partnering 2030

Biopharma Report

Learn what research institutes and biotech companies had to say about partnering with top biopharma companies.

Download biopharma report here